Takaisin Tulosta

Parkinsonin tautiin liittyvät non-motoriset oireet

Lisätietoa aiheesta
Hanna Ruottinen
1.6.2015

Muut autonomisen hermoston häiriöt

Syljen valuminen

Ummetus

Virtsaamishäiriöt

Erektiohäiriöt ja seksuaalitoimintojen häiriöt

Erektiohäiriöt

Seksuaalitoimintojen häiriöt

Muut non-motoriset oireet

Kivut

  • Kipuja arvioidaan esiintyvän noin puolella potilaista «Waseem S, Gwinn-Hardy K. Pain in Parkinson's disea...»22.
  • Useimmiten kivut liittyvät lisääntyneeseen lihasjäykkyyteen tai dystoniaan, harvemmin muihin dyskinesioihin.
  • Kivut paikantuvat vartaloon tai raajojen tyviosiin, tyypillisimmin hartia-olkavarsiseutuun.
  • Kontrolloituja tutkimuksia kipujen hoidosta ei ole.
  • Kipujen hoitona on useimmiten lääkityksen tasapainotus.
  • Tulehduskipulääkkeistä on vain vähän hyötyä.

Kirjallisuutta

  1. Kalf JG, de Swart BJ, Borm GF ym. Prevalence and definition of drooling in Parkinson's disease: a systematic review. J Neurol 2009;256:1391-6 «PMID: 19288042»PubMed
  2. Arbouw ME, Movig KL, Koopmann M ym. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 2010;74:1203-7 «PMID: 20385892»PubMed
  3. Racette BA, Good L, Sagitto S ym. Botulinum toxin B reduces sialorrhea in parkinsonism. Mov Disord 2003;18:1059-61 «PMID: 14502678»PubMed
  4. Lagalla G, Millevolte M, Capecci M ym. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2006;21:704-7 «PMID: 16440332»PubMed
  5. Lagalla G, Millevolte M, Capecci M ym. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling. J Neurol 2009;256:563-7 «PMID: 19401804»PubMed
  6. Marks L, Turner K, O'Sullivan J ym. Drooling in Parkinson's disease: a novel speech and language therapy intervention. Int J Lang Commun Disord 2001;36 Suppl:282-7 «PMID: 11340797»PubMed
  7. South AR, Somers SM, Jog MS. Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study. Neurology 2010;74:1198-202 «PMID: 20385891»PubMed
  8. Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev 2014;1:CD002115 «PMID: 24420006»PubMed
  9. Astarloa R, Mena MA, Sánchez V ym. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin Neuropharmacol 1992;15:375-80 «PMID: 1330307»PubMed
  10. Eichhorn TE, Oertel WH. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 2001;16:1176-7 «PMID: 11748757»PubMed
  11. Zangaglia R, Martignoni E, Glorioso M ym. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord 2007;22:1239-44 «PMID: 17566120»PubMed
  12. Edwards L, Quigley EM, Hofman R ym. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord 1993;8:83-6 «PMID: 8093549»PubMed
  13. Winge K, Skau AM, Stimpel H ym. Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 2006;25:116-22 «PMID: 16402391»PubMed
  14. Yeo L, Singh R, Gundeti M ym. Urinary tract dysfunction in Parkinson's disease: a review. Int Urol Nephrol 2012;44:415-24 «PMID: 21553114»PubMed
  15. Uchiyama T, Sakakibara R, Hattori T ym. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Mov Disord 2003;18:573-8 «PMID: 12722172»PubMed
  16. Campeau L, Soler R, Andersson KE. Bladder dysfunction and parkinsonism: current pathophysiological understanding and management strategies. Curr Urol Rep 2011;12:396-403 «PMID: 21986769»PubMed
  17. Yeo L, Singh R, Gundeti M ym. Urinary tract dysfunction in Parkinson's disease: a review. Int Urol Nephrol 2012;44:415-24 «PMID: 21553114»PubMed
  18. Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord 1995;10:337-40 «PMID: 7651453»PubMed
  19. Raffaele R, Vecchio I, Giammusso B ym. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease. Eur Urol 2002;41:382-6 «PMID: 12074807»PubMed
  20. Basson R. Sex and idiopathic Parkinson's disease. Adv Neurol 2001;86:295-300 «PMID: 11553989»PubMed
  21. Uitti RJ, Tanner CM, Rajput AH ym. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-83 «PMID: 2575449»PubMed
  22. Waseem S, Gwinn-Hardy K. Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable. Postgrad Med 2001;110:33-4, 39-40, 46 «PMID: 11787406»PubMed